Market Closed -
NSE India S.E.
07:43:47 2024-05-10 am EDT
|
5-day change
|
1st Jan Change
|
1,128
INR
|
+1.10%
|
|
-2.09%
|
+4.02%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
459,504
|
242,081
|
516,388
|
391,729
|
303,575
|
660,675
|
-
|
-
|
Enterprise Value (EV)
1 |
507,464
|
267,882
|
514,018
|
373,557
|
291,348
|
642,334
|
624,866
|
597,813
|
P/E ratio
|
19.4
x
|
8.55
x
|
9.68
x
|
14.8
x
|
15.7
x
|
21.1
x
|
17.4
x
|
15.3
x
|
Yield
|
0.32%
|
0.73%
|
0.45%
|
0.67%
|
0.58%
|
0.36%
|
0.44%
|
0.4%
|
Capitalization / Revenue
|
2.35
x
|
1.05
x
|
2.08
x
|
1.67
x
|
1.22
x
|
2.3
x
|
2.1
x
|
1.94
x
|
EV / Revenue
|
2.59
x
|
1.16
x
|
2.07
x
|
1.59
x
|
1.17
x
|
2.24
x
|
1.98
x
|
1.75
x
|
EV / EBITDA
|
13
x
|
5.55
x
|
9.64
x
|
8.52
x
|
7.86
x
|
11.3
x
|
9.48
x
|
8.16
x
|
EV / FCF
|
258
x
|
8.93
x
|
27.2
x
|
12.6
x
|
-90.3
x
|
41.4
x
|
22.7
x
|
17.2
x
|
FCF Yield
|
0.39%
|
11.2%
|
3.68%
|
7.93%
|
-1.11%
|
2.42%
|
4.41%
|
5.8%
|
Price to Book
|
3.31
x
|
1.44
x
|
2.35
x
|
1.59
x
|
1.13
x
|
2.23
x
|
2.01
x
|
1.79
x
|
Nbr of stocks (in thousands)
|
585,916
|
585,939
|
585,939
|
585,939
|
585,939
|
585,939
|
-
|
-
|
Reference price
2 |
784.2
|
413.2
|
881.3
|
668.6
|
518.1
|
1,128
|
1,128
|
1,128
|
Announcement Date
|
5/28/19
|
6/3/20
|
5/31/21
|
5/30/22
|
5/27/23
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
195,636
|
230,985
|
247,746
|
234,555
|
248,554
|
286,694
|
314,888
|
341,054
|
EBITDA
1 |
38,917
|
48,246
|
53,334
|
43,868
|
37,070
|
56,721
|
65,911
|
73,288
|
EBIT
1 |
32,237
|
38,579
|
42,780
|
33,324
|
24,624
|
40,928
|
48,967
|
54,465
|
Operating Margin
|
16.48%
|
16.7%
|
17.27%
|
14.21%
|
9.91%
|
14.28%
|
15.55%
|
15.97%
|
Earnings before Tax (EBT)
1 |
30,914
|
37,430
|
73,436
|
33,727
|
26,125
|
43,538
|
51,164
|
57,233
|
Net income
1 |
23,647
|
28,310
|
53,348
|
26,482
|
19,275
|
31,344
|
37,915
|
42,749
|
Net margin
|
12.09%
|
12.26%
|
21.53%
|
11.29%
|
7.75%
|
10.93%
|
12.04%
|
12.53%
|
EPS
2 |
40.36
|
48.32
|
91.04
|
45.19
|
32.90
|
53.33
|
64.96
|
73.62
|
Free Cash Flow
1 |
1,964
|
29,985
|
18,910
|
29,636
|
-3,226
|
15,525
|
27,532
|
34,660
|
FCF margin
|
1%
|
12.98%
|
7.63%
|
12.63%
|
-1.3%
|
5.42%
|
8.74%
|
10.16%
|
FCF Conversion (EBITDA)
|
5.05%
|
62.15%
|
35.46%
|
67.56%
|
-
|
27.37%
|
41.77%
|
47.29%
|
FCF Conversion (Net income)
|
8.3%
|
105.92%
|
35.45%
|
111.91%
|
-
|
49.53%
|
72.61%
|
81.08%
|
Dividend per Share
2 |
2.500
|
3.000
|
4.000
|
4.500
|
3.000
|
4.077
|
4.979
|
4.501
|
Announcement Date
|
5/28/19
|
6/3/20
|
5/31/21
|
5/30/22
|
5/27/23
|
-
|
-
|
-
|
Fiscal Period: March |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
63,649
|
60,015
|
57,020
|
59,419
|
60,022
|
58,094
|
62,359
|
57,394
|
64,071
|
64,730
|
68,505
|
68,555
|
74,327
|
73,148
|
77,696
|
EBITDA
1 |
13,541
|
12,747
|
12,094
|
11,867
|
10,163
|
9,744
|
9,365
|
7,896
|
9,538
|
9,963
|
11,514
|
11,963
|
15,419
|
15,236
|
-
|
EBIT
1 |
10,776
|
10,087
|
9,297
|
8,925
|
7,172
|
5,888
|
6,570
|
4,915
|
6,324
|
6,508
|
8,248
|
8,567
|
12,165
|
11,190
|
11,654
|
Operating Margin
|
16.93%
|
16.81%
|
16.3%
|
15.02%
|
11.95%
|
10.14%
|
10.54%
|
8.56%
|
9.87%
|
10.05%
|
12.04%
|
12.5%
|
16.37%
|
15.3%
|
15%
|
Earnings before Tax (EBT)
1 |
40,054
|
10,609
|
10,177
|
9,676
|
7,938
|
5,936
|
6,790
|
5,234
|
6,801
|
7,301
|
8,120
|
8,800
|
11,846
|
11,498
|
-
|
Net income
1 |
29,465
|
8,016
|
7,700
|
6,970
|
6,047
|
5,765
|
5,205
|
4,094
|
4,913
|
5,063
|
5,708
|
6,061
|
8,749
|
8,361
|
-
|
Net margin
|
46.29%
|
13.36%
|
13.5%
|
11.73%
|
10.08%
|
9.92%
|
8.35%
|
7.13%
|
7.67%
|
7.82%
|
8.33%
|
8.84%
|
11.77%
|
11.43%
|
-
|
EPS
2 |
50.29
|
13.67
|
13.14
|
11.89
|
10.32
|
9.840
|
8.880
|
6.990
|
8.380
|
8.640
|
9.740
|
10.66
|
16.32
|
14.89
|
14.59
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/10/21
|
5/31/21
|
8/12/21
|
11/8/21
|
2/9/22
|
5/30/22
|
8/11/22
|
11/12/22
|
2/9/23
|
5/27/23
|
8/12/23
|
-
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
47,960
|
25,802
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
2,370
|
18,172
|
12,227
|
18,341
|
35,809
|
62,862
|
Leverage (Debt/EBITDA)
|
1.232
x
|
0.5348
x
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
1,964
|
29,985
|
18,910
|
29,636
|
-3,226
|
15,525
|
27,532
|
34,660
|
ROE (net income / shareholders' equity)
|
19%
|
20.3%
|
17%
|
11.8%
|
7.5%
|
11.2%
|
12%
|
12.2%
|
ROA (Net income/ Total Assets)
|
10.2%
|
11.3%
|
10.5%
|
8.11%
|
5.22%
|
8.23%
|
9.67%
|
10.1%
|
Assets
1 |
231,193
|
251,405
|
508,929
|
326,497
|
369,041
|
380,732
|
392,208
|
421,462
|
Book Value Per Share
2 |
237.0
|
287.0
|
374.0
|
419.0
|
458.0
|
506.0
|
562.0
|
629.0
|
Cash Flow per Share
2 |
27.70
|
74.80
|
56.80
|
85.60
|
40.70
|
58.50
|
75.90
|
87.90
|
Capex
1 |
14,257
|
13,828
|
14,379
|
20,529
|
24,038
|
20,726
|
15,733
|
15,449
|
Capex / Sales
|
7.29%
|
5.99%
|
5.8%
|
8.75%
|
9.67%
|
7.23%
|
5%
|
4.53%
|
Announcement Date
|
5/28/19
|
6/3/20
|
5/31/21
|
5/30/22
|
5/27/23
|
-
|
-
|
-
|
Last Close Price
1,128
INR Average target price
1,195
INR Spread / Average Target +5.95% Consensus |
1st Jan change
|
Capi.
|
---|
| +4.02% | 7.91B | | +30.38% | 684B | | +26.51% | 568B | | -4.36% | 361B | | +19.30% | 329B | | +3.73% | 284B | | +16.70% | 240B | | +8.78% | 208B | | -7.93% | 200B | | +7.68% | 166B |
Other Pharmaceuticals
|